Genmab A/S (FRA:GE9)
Germany · Delayed Price · Currency is EUR 272.60
-2.80 (-1.02%)
At close: Jan 30, 2026
Genmab Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 1,583 | 1,089 | 645.39 | 783.33 | 452.29 | 781.94 |
Depreciation & Amortization | 71.88 | 57.33 | 43.75 | 52.01 | 29.67 | 43.71 |
Asset Writedown & Restructuring Costs | 8.07 | 15.96 | - | - | - | 4.77 |
Loss (Gain) From Sale of Investments | -87.8 | -34.29 | -43.45 | 94.54 | 105.39 | -143.47 |
Stock-Based Compensation | 127.27 | 100.09 | 86.9 | 63.07 | 47.42 | 32.87 |
Other Operating Activities | -303.94 | -46.78 | 159.86 | -166.52 | -186.15 | 175.19 |
Change in Accounts Receivable | -180.78 | -220.73 | 118.19 | -305.03 | -154.33 | 50.29 |
Change in Inventory | -3.79 | -0.69 | -8.45 | - | - | - |
Change in Accounts Payable | 154.63 | 118.97 | 92.24 | 40.66 | 46.5 | 27.61 |
Change in Unearned Revenue | - | - | - | - | - | 84.31 |
Operating Cash Flow | 1,369 | 1,079 | 1,094 | 562.07 | 340.79 | 1,057 |
Operating Cash Flow Growth | 35.97% | -1.43% | 94.72% | 64.93% | -67.77% | 430.89% |
Capital Expenditures | -40.38 | -25.96 | -54.28 | -45.55 | -38.55 | -50.45 |
Cash Acquisitions | -140.81 | -1,700 | - | - | - | - |
Sale (Purchase) of Intangibles | -34.38 | -16.24 | -1.48 | - | - | - |
Investment in Securities | 47.21 | 366.91 | -134.36 | -351.15 | -108.45 | -335.91 |
Investing Cash Flow | -168.36 | -1,375 | -190.12 | -396.7 | -146.99 | -386.37 |
Long-Term Debt Repaid | - | -8.33 | -13.5 | -10.49 | -8.87 | -7.23 |
Net Debt Issued (Repaid) | -12.43 | -8.33 | -13.5 | -10.49 | -8.87 | -7.23 |
Issuance of Common Stock | 18.27 | 17.91 | 22.54 | 40.23 | 20.65 | 23.01 |
Repurchase of Common Stock | -497.5 | -553.62 | -98.91 | -143.1 | -76.02 | -4.11 |
Financing Cash Flow | -491.66 | -544.04 | -89.87 | -113.36 | -64.24 | 11.67 |
Foreign Exchange Rate Adjustments | 137.32 | 145.21 | -76.82 | 82.47 | 130.01 | -73.13 |
Net Cash Flow | 846.1 | -695.36 | 737.63 | 134.48 | 259.57 | 609.38 |
Free Cash Flow | 1,328 | 1,053 | 1,040 | 516.52 | 302.24 | 1,007 |
Free Cash Flow Growth | 35.17% | 1.22% | 101.38% | 70.90% | -69.98% | 437.58% |
Free Cash Flow Margin | 34.54% | 35.23% | 42.58% | 24.79% | 23.48% | 60.59% |
Free Cash Flow Per Share | 21.06 | 16.29 | 15.78 | 7.83 | 4.58 | 15.28 |
Cash Interest Paid | 5.5 | 4.86 | 3.71 | 2.3 | 1.84 | 3.29 |
Cash Income Tax Paid | 321.88 | 47.62 | 158.23 | 227.44 | 113.49 | 242.57 |
Levered Free Cash Flow | 955.98 | 867.97 | 789.22 | 305.1 | 259.8 | 768.36 |
Unlevered Free Cash Flow | 972.14 | 878.38 | 795.71 | 308.6 | 261.04 | 769.39 |
Change in Working Capital | -29.94 | -102.45 | 201.98 | -264.37 | -107.83 | 162.21 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.